863P - Cabazitaxel for octogenarian patients with metastatic castration-resistant prostate cancer (MCRPC)

Autor: Tralongo, P., Bordonaro, S., Lorenzo, G Di, Borsellino, N., Facchini, G., Rossetti, S., Martelli, V., Longo, V., Tralongo, A.C., Caspani, F., Tuzi, A., Spada, M., Calvani, N., Carlini, P., De Giorgi, U.F.F.
Zdroj: In Annals of Oncology October 2019 30 Supplement 5:v337-v337
Databáze: ScienceDirect